1 Renin and atrial natriuretic peptide restriction fragment length polymorphisms: association with ethnicity and blood pressure.

2 Cardiac secretion of B - type natriuretic peptide ( BNP ) increases with the progression of heart failure ( HF ).

3 Nesiritide is a synthetic form of brain natriuretic peptide using recombinant DNA technology.

4 This article reviews the relationship between brain natriuretic peptide and cerebral vascular disease.

5 Objective To discuss the value of atrial natriuretic ANP in differentiating benign and malignant pleural effusion.

6 Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure. Redefining the Cardiorenal Interaction?

7 Atrial natriuretic peptide ( ANP ) plays an important role in the regulation of blood pressure through sodium - water homoeostasis.

8 The plasma levels of atrial natriuretic factor (ANF) and prekallikrein(PK) were measured in Fatients with essential hypertension and in health subjects as a control.

9 Objective To investigate the changes of the dendroaspis natriuretic peptide (DNP) levels after severe brain trauma and its relations with the occurrence of hyponatremia and the fluid balance.

10 Atrial natriuretic peptide in plasma dilates veins and arteries, acts as a diuretic and inhibits neurohumoral effects.

11 Elevated B - type natriuretic peptide levels have associated with the risk of heart failure, AF, and mortality.

12 Objective:To evaluate diagnostic value of plasma brain natriuretic peptide(BNP) and Nterminal atrial natriuretic peptide (NANP) in patients with silent heart failure (SHF).

13 Atrial natriuretic peptide in plasma dilates and arteries, acts as a diuretic and inhibits neurohumoral effects.

14 Objective B - type natriuretic peptide ( BNP ) is used as prognostic marker in acute coronary syndromes.

15 The amino-terminal pro-brain natriuretic peptide (NT-proBNP) was measured by using electrochemiluminescence to evaluate the changes in cardiac function indirectly.

16 Objective To assess B type natriuretic peptide (BNP) levels measurement value in differentiating etiology of dyspnea in the octogenarian.

17 Brain natriuretic peptide ( BNP ) is a neurohormone secreted mainly in the cardiac ventricles.

18 Through combining natriuretic peptide receptors A and B, nesiritide possesser obvious vasodilatory diuretic and natriuretic effects.

19 Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure. Redefining the Cardiorenal Interaction? van Kimmenade R. R. J. Januzzi Jr. J. L. Baggish A. L.

20 Because of the strong natriuretic effect of Furosemide injection, the sodium levels could be reduced especially if the oedema is reduced quickly.

21 Cardiac neurohormonal markers like B-type natriuretic peptides(BNP) has been identified as a possible tool to identify and treat patients with CHF.

22 Objective B-type natriuretic peptide(BNP) is a neurohormone with diuretic, natriuretic and vasorelaxant properties, which synthesized in the cardiac ventricles.

23 The lower limits of sensitivity for glucagon and atrial natriuretic peptide assay were 3.7 pmol/l and 1.1 pmol/l, respectively.

24 Cardiac ischemia is an important trigger for the rel ea se of B - type natriuretic peptide ( BNP ).

25 L ejection fraction increased 35 % , and pro - brain natriuretic peptide decreased 40 %.

26 The new ideas for diuretics, arginine vasopressin receptor antagonist, natriuretic peptides analogues and ultrafiltration are new advances of natriuresis in the treatment of heart failure.

27 Objective To study the change and the significance of N-terminal pro-brain natriuretic peptide in the COPD patients.

28 Objective To analyze the influence of magnesium on plasmic brain natriuretic peptide level and cardiac function in patients with congestive heart failure.

29 Onset of atrial tachyarrhythmia is often followed by the need to urinate because of increased production of atrial natriuretic factor.

30 Chen : Heart failure patients have a problem in producing enough natriuretic peptides, so we give them shots through subcutaneous injection of the peptides which help their heart.

31 Objective To determine the effects of endothelin-1(ET-1), calcitonin gene-related peptide (CGRP) and atrial natriuretic factor (ANF) in physiopathology of neonatal heart failure.